# US 2010/0163446 A1 · Liquid container

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0163446 A1
- Document ID: US20100163446A1
- Status: Published application
- Kind: A1
- Application number: 12/303,759
- Filed: 2007-06-26
- Published: 2010-07-01
- Earliest claimed: 2006-06-28
- Assignees: Fujimori Kogyo Co., Ltd.
- Inventors: Toyoaki Suzuki; Koichi Miura; Akemi Kishimoto; Kunihiko Kimura; Yoshikazu Kato; Yukie Ito
- Web page: https://patentgrep.com/patent/US20100163446A1

## CPC

- B65D 31/02: {with laminated walls}
- A61J 1/10: Bag-type containers
- B32B 27/32: comprising polyolefins {(comprising vinyl (co)polymers or acrylic (co)polymers B32B27/30)}
- B32B 27/325: {comprising polycycloolefins}
- B32B 2439/00: Containers; Receptacles
- Y10T 428/1341: Contains vapor or gas barrier, polymer derived from vinyl chloride or vinylidene chloride, or polymer containing a vinyl alcohol unit
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- B32B: LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

To provide a liquid container, which exhibits excellent storage stability and impact resistance and which can be used for producing a soft bag pharmaceutical product of an injection liquid containing nitroglycerin, a protein, hyaluronic acid, a vitamin, a trace element, a radical scavenger, and the like. The liquid container of the invention formed of a multilayer film and/or multilayer sheet, characterized in that the multilayer film and/or multilayer sheet has a barrier layer containing, as a predominant component, a polycycloolefin-based resin having a glass transition temperature higher by 5° C. or more than the temperature at which the container is subjected to thermal treatment or high-pressure steam sterilization, and a seal layer containing, as a predominant component, a polyethylene-based resin or a polypropylene-based resin, and the barrier layer being provided adjacent to the seal layer.

## Claims

### Claim 1

A liquid container formed of a multilayer film and/or multilayer sheet, characterized in that the multilayer film and/or multilayer sheet has a barrier layer comprising, as a predominant component, a polycycloolefin-based resin having a glass transition temperature higher by 5° C. or more than the temperature at which the container is subjected to thermal treatment or high-pressure steam sterilization, and a seal layer comprising, as a predominant component, a polyethylene-based resin or a polypropylene-based resin, and the barrier layer being provided adjacent to the seal layer.

### Claim 2 (depends on 1)

The liquid container according to claim 1, wherein the polycycloolefin-based resin is a polycycloolefin-based resin having a glass transition temperature of 130° C. or higher.

### Claim 3 (depends on 1, 2)

The liquid container according to claim 1 or 2, wherein the polyethylene-based resin is a linear low-density polyethylene having a melting point of 110 to 130° C. and/or a high-density polyethylene having a melting point of 120 to 145° C.

### Claim 4 (depends on 1, 2, 3)

The liquid container according to any one of claims 1 to 3, wherein the multilayer film and/or multilayer sheet has, on the surface of the barrier layer opposite to the seal layer, a base layer predominantly comprising linear low-density polyethylene having a melting point of 110 to 130° C. and/or high-density polyethylene having a melting point of 120 to 145° C.

### Claim 5 (depends on 1, 2, 3, 4)

The liquid container according to any one of claims 1 to 4, which has a port member formed of a polyethylene-based resin or a polypropylene-based resin.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The liquid container according to any one of claims 1 to 5, wherein the polycycloolefin-based resin is represented by formula (1):
wherein R1 and R2, which are identical to or different from each other, each represent a C1 to C20 organic group, and R1 and R2 may be linked to form a ring.

### Claim 7 (depends on 6)

The liquid container according to claim 6, wherein the barrier layer is formed solely of a polycycloolefin-based resin.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The liquid container according to any one of claims 1 to 7, which is subjected to a thermal treatment at 60° C. or higher or high-pressure steam sterilization at 105° C. or higher.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

A pharmaceutical product for injection liquid, the pharmaceutical product comprising the liquid container according to any one of claims 1 to 8, filled by a solution of a drug that can be adsorbed by a resin and/or that can permeate a resin.

### Claim 10 (depends on 9)

The pharmaceutical product according to claim 9, wherein the drug which can be adsorbed by a resin and/or which can permeate a resin is a nitroglycerin-containing drug.

### Claim 11 (depends on 9)

The pharmaceutical product according to claim 9, wherein the drug which can be adsorbed by a resin and/or which can permeate a resin is a protein-containing drug, a hyaluronic acid-containing drug, a vitamin-containing drug, a trace element-containing drug, or a radical scavenger-containing drug.

### Claim 12 (depends on 11)

The pharmaceutical product according to claim 11, wherein the protein-containing drug is a drug containing human plasma-derived albumin, albumin produced through a recombination technique, or a hormone.
